sec filing
CL
NASDAQ · CLRB
Cellectar Biosciences, Inc.
Healthcare · Biotechnology
$1.67
Down-$0.16 (-9.58%)
Updated Oct 7, 2026, 1:54 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.1M
- P/E ratio
- -0.21
- Dividend yield
- 0.00%
- 52-week range
- $1.67 – $6.52
- Volume
- 60.68K
- Avg. volume
- 156.38K
Price performance · CLRB
CLRB price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
CLRB closed at $1.67 after 20 trading sessions, down 30.71% for the selected period.
- Last close
- $1.67
- Period change
- -30.71%
- Period low
- $1.67
- Period high
- $2.41
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.79 | $1.79 | $1.67 | $1.67 | 60.68K |
| Oct 2, 2026 | $1.95 | $1.975 | $1.78 | $1.78 | 48.04K |
| Oct 1, 2026 | $1.87 | $1.87 | $1.8201 | $1.87 | 30.18K |
| Sep 30, 2026 | $1.92 | $1.92 | $1.82 | $1.84 | 74.86K |
| Sep 29, 2026 | $1.98 | $1.98 | $1.8062 | $1.82 | 86.03K |
| Sep 28, 2026 | $1.80 | $1.8901 | $1.80 | $1.83 | 65.02K |
| Sep 25, 2026 | $2.07 | $2.09 | $1.80 | $1.80 | 124.58K |
| Sep 24, 2026 | $2.13 | $2.15 | $1.9603 | $2.075 | 55.49K |
| Sep 23, 2026 | $2.25 | $2.3086 | $2.06 | $2.09 | 72.94K |
| Sep 22, 2026 | $2.36 | $2.37 | $2.1743 | $2.23 | 161.24K |
| Sep 21, 2026 | $2.37 | $2.4196 | $2.35 | $2.35 | 50.01K |
| Sep 18, 2026 | $2.39 | $2.44 | $2.37 | $2.38 | 73.56K |
| Sep 17, 2026 | $2.37 | $2.44 | $2.37 | $2.40 | 71.67K |
| Sep 16, 2026 | $2.32 | $2.39 | $2.32 | $2.35 | 73.03K |
| Sep 15, 2026 | $2.31 | $2.34 | $2.28 | $2.32 | 33.37K |
| Sep 14, 2026 | $2.33 | $2.45 | $2.29 | $2.31 | 65.75K |
| Sep 11, 2026 | $2.35 | $2.40 | $2.31 | $2.31 | 38.39K |
| Sep 10, 2026 | $2.35 | $2.40 | $2.35 | $2.37 | 18.89K |
| Sep 9, 2026 | $2.41 | $2.45 | $2.35 | $2.365 | 44.38K |
| Sep 8, 2026 | $2.46 | $2.47 | $2.375 | $2.41 | 27.56K |
Latest CLRB news
The latest Smart Investors Daily articles mentioning CLRB.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…